Patricia L Kavanagh

Summary

Affiliation: Boston University School of Medicine
Country: USA

Publications

  1. doi request reprint Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states
    Patricia L Kavanagh
    Division of General Pediatrics, Boston University School of Medicine Boston Medical Center, Boston, MA 02118, USA
    Am J Med Genet C Semin Med Genet 148:15-22. 2008
  2. pmc Quality indicators and quality assessment in child health
    P L Kavanagh
    Division of General Pediatrics, Boston University School of Medicine Boston Medical Center, Boston, MA 02118, USA
    Arch Dis Child 94:458-63. 2009
  3. doi request reprint Translating scientific advances to improved outcomes for children with sickle cell disease: a timely opportunity
    Jean L Raphael
    Department of Pediatrics, Baylor College of Medicine, Texas Children s Cancer Center, Houston, Texas, USA
    Pediatr Blood Cancer 56:1005-8. 2011
  4. doi request reprint Management of children with sickle cell disease: a comprehensive review of the literature
    Patricia L Kavanagh
    Department of Pediatrics, Boston University School of Medicine, Boston, MA 02118, USA
    Pediatrics 128:e1552-74. 2011
  5. doi request reprint Pasteurized human donor milk use among US level 3 neonatal intensive care units
    Margaret G K Parker
    Department of Pediatrics, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA
    J Hum Lact 29:381-9. 2013
  6. doi request reprint Quality-of-care indicators for children with sickle cell disease
    C Jason Wang
    Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts, USA
    Pediatrics 128:484-93. 2011

Collaborators

Detail Information

Publications6

  1. doi request reprint Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states
    Patricia L Kavanagh
    Division of General Pediatrics, Boston University School of Medicine Boston Medical Center, Boston, MA 02118, USA
    Am J Med Genet C Semin Med Genet 148:15-22. 2008
    ..1-2.5%). Wide variation exists in stakeholder notification by NBS programs of positive screenings for SCD and trait. This variation may alter the effectiveness of NBS programs by location of birth...
  2. pmc Quality indicators and quality assessment in child health
    P L Kavanagh
    Division of General Pediatrics, Boston University School of Medicine Boston Medical Center, Boston, MA 02118, USA
    Arch Dis Child 94:458-63. 2009
    ..The convergence of quality measurement and indicator development, a growing scientific evidence base and integrated information systems in healthcare may lead to substantial improvements for child health in the 21st century...
  3. doi request reprint Translating scientific advances to improved outcomes for children with sickle cell disease: a timely opportunity
    Jean L Raphael
    Department of Pediatrics, Baylor College of Medicine, Texas Children s Cancer Center, Houston, Texas, USA
    Pediatr Blood Cancer 56:1005-8. 2011
    ....
  4. doi request reprint Management of children with sickle cell disease: a comprehensive review of the literature
    Patricia L Kavanagh
    Department of Pediatrics, Boston University School of Medicine, Boston, MA 02118, USA
    Pediatrics 128:e1552-74. 2011
    ....
  5. doi request reprint Pasteurized human donor milk use among US level 3 neonatal intensive care units
    Margaret G K Parker
    Department of Pediatrics, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA
    J Hum Lact 29:381-9. 2013
    ....
  6. doi request reprint Quality-of-care indicators for children with sickle cell disease
    C Jason Wang
    Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts, USA
    Pediatrics 128:484-93. 2011
    ..To develop a set of quality-of-care indicators for the management of children with sickle cell disease (SCD) who are cared for in a variety of settings by addressing the broad spectrum of complications relevant to their illness...